newsfilter
← Latest News
GlobeNewswire·

ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020

TRYbeCA-1 Phase 3 trial in second-line metastatic pancreatic cancer: More than 90% of the planned 500 patients enrolled Fast-Track designation granted by U.S. FDAInterim superiority analysis expected...